Management of nonalcoholic fatty liver disease in the Middle East

The prevalence of nonalcoholic fatty liver disease (NAFLD) in the Middle East is increasing in parallel to an increase in the prevalence of associated risk factors such as obesity, metabolic syndrome, and type 2 diabetes mellitus. About 20% to 30% of the patients progress to develop nonalcoholic ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanai, Faisal M, Abaalkhail, Faisal, Hasan, Fuad, Farooqi, Muhammad Hamed, Nahdi, Nawal Al, Younossi, Zobair M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366060/
https://www.ncbi.nlm.nih.gov/pubmed/32742124
http://dx.doi.org/10.3748/wjg.v26.i25.3528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366060/
https://www.ncbi.nlm.nih.gov/pubmed/32742124
http://dx.doi.org/10.3748/wjg.v26.i25.3528

Ejemplares similares